{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:04:55Z","timestamp":1747181095287,"version":"3.40.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,24]]},"abstract":"<jats:p>During the coronavirus disease 2019 pandemic, Ayurvedic herbal supplements and homeopathic immune boosters (IBs) were promoted as disease-preventive agents. The present study examined the clinical outcomes among patients with chronic liver disease who presented with complications of portal hypertension or liver dysfunction temporally associated with the use of IBs in the absence of other competing causes. This single-center retrospective observational cohort study included patients with chronic liver disease admitted for the evaluation and management of jaundice, ascites, or hepatic encephalopathy temporally associated with the consumption of IBs and followed up for 180 days. Chemical analysis was performed on the retrieved IBs. From April 2020 to May 2021, 1022 patients with cirrhosis were screened, and 178 (19.8%) were found to have consumed complementary and alternative medicines. Nineteen patients with cirrhosis (10.7%), jaundice, ascites, hepatic encephalopathy, or their combination related to IBs use were included. The patients were predominantly male (89.5%). At admission, 14 (73.75%) patients had jaundice, 9 (47.4%) had ascites, 2 (10.5%) presented with acute kidney injury, and 1 (5.3%) had overt encephalopathy. Eight patients (42.1%) died at the end of the follow up period. Hepatic necrosis and portal-based neutrophilic inflammation were the predominant features of liver biopsies. IB analysis revealed detectable levels of (heavy metals) As (40%), Pb (60%), Hg (60%), and various hepatotoxic phytochemicals. Ayurvedic and Homeopathic supplements sold as IBs potentially cause the worsening of preexisting liver disease. Responsible dissemination of scientifically validated, evidence-based medical health information from regulatory bodies and media may help ameliorate this modifiable liver health burden.<\/jats:p>","DOI":"10.1097\/md.0000000000033365","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T13:06:29Z","timestamp":1679663189000},"page":"e33365","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical outcomes associated with complementary and alternative medicine-related \u201cimmunity-boosting\u201d practices in patients with cirrhosis during the COVID-19 pandemic \u2013 an observational study"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-336X","authenticated-orcid":false,"given":"Cyriac Abby","family":"Philips","sequence":"first","affiliation":[{"name":"Clinical and Translational Hepatology, The Liver Institute, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif Hussain","family":"Theruvath","sequence":"additional","affiliation":[{"name":"Complementary and Alternative Medicine (Homeopathy), Department of Clinical Research, The Liver Institute, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resmi","family":"Raveendran","sequence":"additional","affiliation":[{"name":"Complementary and Alternative Medicine (Ayurveda), Department of Clinical Research, The Liver Institute, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan","family":"Ahamed","sequence":"additional","affiliation":[{"name":"Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasidharan","family":"Rajesh","sequence":"additional","affiliation":[{"name":"Interventional Radiology, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsha K","family":"Abduljaleel","sequence":"additional","affiliation":[{"name":"Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit","family":"Tharakan","sequence":"additional","affiliation":[{"name":"Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Augustine","sequence":"additional","affiliation":[{"name":"Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities.","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-021-00527-1","article-title":"COVID-19 in early 2021: current status and looking forward.","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13223-020-00474-6","article-title":"\u201cImmune boosting\u201d in the time of COVID: selling immunity on instagram.","volume":"16","author":"Wagner","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e040989","DOI":"10.1136\/bmjopen-2020-040989","article-title":"COVID-19 and \u201cimmune boosting\u201d on the internet: a content analysis of Google search results.","volume":"10","author":"Rachul","year":"2020","journal-title":"BMJ Open"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jceh.2021.08.026","article-title":"Tinospora cordifolia (Giloy) and autoimmune-like liver injury - a classic case of primum non nocere, \u201cfirst, do no harm.\u201d [published online ahead of print, 2021 Sep 4].","volume":"12","author":"Philips","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"929","DOI":"10.14309\/ajg.0000000000000201","article-title":"Drug-induced acute-on-chronic liver failure in Asian patients.","volume":"114","author":"Devarbhavi","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12664-017-0815-8","article-title":"Clinical outcomes, histopathological patterns, and chemical analysis of ayurveda and herbal medicine associated with severe liver injury-a single-center experience from southern India.","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep4.1355","article-title":"A single-center experience on outcomes of complementary and alternative medicine use among patients with cirrhosis.","volume":"3","author":"Philips","year":"2019","journal-title":"Hepatol Commun"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/liv.14393","article-title":"Ashwagandha-induced liver injury: a case series from Iceland and the US drug-induced liver injury network.","volume":"40","author":"Bj\u00f6rnsson","year":"2020","journal-title":"Liver Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.14309\/ajg.0000000000001369","article-title":"Ashwagandha-induced liver injury: self-reports on commercial websites as useful adjunct tools for causality assessment.","volume":"116","author":"Weber","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/0975-9476.93948","article-title":"Evaluating higher doses of Shunthi - Guduchi formulations for safety in treatment of osteoarthritis knees: a Government of India NMITLI arthritis project.","volume":"3","author":"Chopra","year":"2012","journal-title":"J Ayurveda Integr Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bcp.14460","article-title":"Acute liver injury following turmeric use in Tuscany: an analysis of the Italian Phytovigilance database and systematic review of case reports.","volume":"87","author":"Lombardi","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"6741213","DOI":"10.1155\/2019\/6741213","article-title":"Turmeric induced liver injury: a report of two cases.","volume":"2019","author":"Luber","year":"2019","journal-title":"Case Reports Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e00320","DOI":"10.14309\/crj.0000000000000320","article-title":"Autoimmune hepatitis associated with turmeric consumption.","volume":"7","author":"Lee","year":"2020","journal-title":"ACG Case Rep J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jceh.2021.11.014","article-title":"Liver injury following tinospora cordifolia consumption: drug induced AIH, or de novo AIH?","volume":"12","author":"Bj\u00f6rnsson","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/phrev.phrev_17_17","article-title":"Psidium guajava: a single plant for multiple health problems of rural Indian population.","volume":"11","author":"Daswani","year":"2017","journal-title":"Pharmacogn Rev"},{"key":"R19-20250504","first-page":"289","article-title":"Toxicity study of psidium guajava Linn. Leaves.","volume":"37","author":"Attawish","year":"1995","journal-title":"Warasan Krom Witthayasat Kan Phaet"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-017-2062-2","article-title":"Hepatotoxicity of monoterpenes and sesquiterpenes.","volume":"92","author":"Z\u00e1rybnick\u00fd","year":"2018","journal-title":"Arch Toxicol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/a-0605-3786","article-title":"A review of the toxicity of compounds found in herbal dietary supplements.","volume":"84","author":"Hudson","year":"2018","journal-title":"Planta Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.3390\/ijms21145011","article-title":"Potential hepatotoxins found in herbal medicinal products: a systematic review.","volume":"21","author":"Quan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements.","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia pacific association of study of liver consensus guidelines.","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol Int"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases.","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease.","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14218\/JCTH.2019.00043","article-title":"Outcomes and toxicology of herbal drugs in alcoholic hepatitis - a single center experience from India.","volume":"7","author":"Philips","year":"2019","journal-title":"J Clin Transl Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:36:46Z","timestamp":1746326206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033365","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,3,24]]}}}